Published in Blood Weekly, September 28th, 2000
"This is an important first step," said Howard Gendelman, MD, director of the UNMC Center for Neurovirology and Neurodegenerative Disorders. "If further studies indicate that cells obtained in this fashion are useful in our research, a reduction in the amount of fetal tissue from elective abortions needed for the research is possible."
Only a handful of institutions in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.